Abstract
BackgroundThe goal in treating RA has changed from clinical remission to structural remission with the increased use of biological agents (Bio) which target the pro-inflammatory cytokines interleukin (IL)-6 and tumor...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have